Cigall Kadoch

Cigall Kadoch, PhD, is an academic leader and entrepreneur in the biomedical sciences. She is a Professor and Meredith and Billy Starr Investigator of Pediatric Oncology at the Dana-Farber Cancer Institute, an Institute Member and Epigenomics Program Co-Director at the Broad Institute, and an Investigator of the Howard Hughes Medical Institute (HHMI). Dr. Kadoch is a leading expert in chromatin and gene regulation and is internationally recognized for her groundbreaking studies in these areas. Specifically, her laboratory studies the structure and function of nuclear protein complexes called chromatin remodeling complexes that govern DNA architecture and gene expression, perturbations or dependencies that are implicated in more than 50% of human cancers. Dr. Kadoch is also the Scientific Founder of Foghorn Therapeutics, a company advancing a new class of medicines that target the chromatin regulatory machinery.